Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Nature communications·2024
Same author

Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.

Cell death & disease·2022
Same author

A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants.

Infection and immunity·2022
Same author

Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite.

Journal for immunotherapy of cancer·2022
Same author

Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients.

Infection and immunity·2021
Same author

Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.

Cell chemical biology·2020

Related Experiment Video

Updated: May 27, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

T cell depleted haploidentical transplantation: positive selection.

Franco Aversa1

  • 1Pediatric Oncology/Hematology, BMT Unit, Section of Hematology, Department of Internal and Experimental Medicine, University of Perugia, Perugia, Italy.

Pediatric Reports
|November 5, 2011
PubMed
Summary

One-haplotype mismatched transplants offer a readily available donor option for patients needing allogeneic transplants. This approach demonstrates excellent engraftment and low GVHD rates, comparing favorably with other stem cell sources.

Keywords:
T cell depleted haploidentical transplantation.

More Related Videos

Examination of Thymic Positive and Negative Selection by Flow Cytometry
14:29

Examination of Thymic Positive and Negative Selection by Flow Cytometry

Published on: October 8, 2012

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Related Experiment Videos

Last Updated: May 27, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Examination of Thymic Positive and Negative Selection by Flow Cytometry
14:29

Examination of Thymic Positive and Negative Selection by Flow Cytometry

Published on: October 8, 2012

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Area of Science:

  • Immunology
  • Hematology
  • Transplantation Medicine

Background:

  • A significant unmet need exists for readily available stem cell donors for allogeneic transplantation.
  • One-haplotype mismatched donors are accessible for most patients, offering a timely alternative.

Purpose of the Study:

  • To review the advancements and outcomes of one-haplotype mismatched stem cell transplantation.
  • To evaluate the efficacy and safety of novel transplant techniques in this setting.

Main Methods:

  • Focus on conditioning regimens and post-transplant immunosuppression strategies.
  • Graft manipulation techniques, including megadose T cell-depleted or unmanipulated progenitor cells.
  • Analysis of engraftment rates, graft-versus-host disease (GVHD), and regimen-related mortality.

Main Results:

  • Excellent engraftment rates achieved in one-haplotype mismatched transplants.
  • Low incidence of both acute and chronic GVHD observed.
  • Favorable transplant-related mortality and event-free survival rates, even in older patients (>50 years).

Conclusions:

  • One-haplotype mismatched transplantation is a viable and effective strategy for patients lacking matched sibling donors.
  • Outcomes are comparable or superior to transplants from alternative stem cell sources.
  • This approach improves accessibility and survival for patients requiring urgent allogeneic transplants.